Literature DB >> 25733582

EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice.

Hai Po H Liang1, Edward J Kerschen1, Irene Hernandez1, Sreemanti Basu1, Mark Zogg1, Fady Botros1, Shuang Jia2, Martin J Hessner2, John H Griffin3, Wolfram Ruf4, Hartmut Weiler5.   

Abstract

Infection and inflammation are invariably associated with activation of the blood coagulation mechanism, secondary to the inflammation-induced expression of the coagulation initiator tissue factor (TF) on innate immune cells. By investigating the role of cell-surface receptors for coagulation factors in mouse endotoxemia, we found that the protein C receptor (ProcR; EPCR) was required for the normal in vivo and in vitro induction of lipopolysaccharide (LPS)-regulated gene expression. In cultured bone marrow-derived myeloid cells and in monocytic RAW264.7 cells, the LPS-induced expression of functionally active TF, assembly of the ternary TF-VIIa-Xa initiation complex of blood coagulation, and the EPCR-dependent activation of protease-activated receptor 2 (PAR2) by the ternary TF-VIIa-Xa complex were required for the normal LPS induction of messenger RNAs encoding the TLR3/4 signaling adaptor protein Pellino-1 and the transcription factor interferon regulatory factor 8. In response to in vivo challenge with LPS, mice lacking EPCR or PAR2 failed to fully initiate an interferon-regulated gene expression program that included the Irf8 target genes Lif, Iigp1, Gbp2, Gbp3, and Gbp6. The inflammation-induced expression of TF and crosstalk with EPCR, PAR2, and TLR4 therefore appear necessary for the normal evolution of interferon-regulated host responses.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25733582      PMCID: PMC4424632          DOI: 10.1182/blood-2014-11-610717

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  53 in total

1.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

2.  Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.

Authors:  Katrine S Larsen; Henrik Ostergaard; Ole H Olsen; Jais R Bjelke; Wolfram Ruf; Lars C Petersen
Journal:  J Biol Chem       Date:  2010-04-13       Impact factor: 5.157

3.  IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors.

Authors:  Amy M Becker; Drew G Michael; Ansuman T Satpathy; Roger Sciammas; Harinder Singh; Deepta Bhattacharya
Journal:  Blood       Date:  2012-01-11       Impact factor: 22.113

4.  Identification of IRF-8 and IRF-1 target genes in activated macrophages.

Authors:  Natalie Dror; Michal Alter-Koltunoff; Aviva Azriel; Ninette Amariglio; Jasmine Jacob-Hirsch; Sharon Zeligson; Avigail Morgenstern; Tomohiko Tamura; Hansjörg Hauser; Gideon Rechavi; Keiko Ozato; Ben-Zion Levi
Journal:  Mol Immunol       Date:  2006-04-04       Impact factor: 4.407

5.  The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors.

Authors:  Jennifer Disse; Helle Heibroch Petersen; Katrine S Larsen; Egon Persson; Naomi Esmon; Charles T Esmon; Luc Teyton; Lars C Petersen; Wolfram Ruf
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

6.  Regulation of tissue factor--mediated initiation of the coagulation cascade by cell surface grp78.

Authors:  Gourab Bhattacharjee; Jasimuddin Ahamed; Brian Pedersen; Amr El-Sheikh; Nigel Mackman; Wolfram Ruf; Cheng Liu; Thomas S Edgington
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-09       Impact factor: 8.311

Review 7.  Thrombosis as an intravascular effector of innate immunity.

Authors:  Bernd Engelmann; Steffen Massberg
Journal:  Nat Rev Immunol       Date:  2012-12-07       Impact factor: 53.106

8.  Role of cardiac myocyte tissue factor in heart hemostasis.

Authors:  R Pawlinski; M Tencati; T Holscher; B Pedersen; T Voet; R E Tilley; P Marynen; N Mackman
Journal:  J Thromb Haemost       Date:  2007-08       Impact factor: 5.824

9.  Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis.

Authors:  Jean-François Marquis; Oxana Kapoustina; David Langlais; Rebecca Ruddy; Catherine Rosa Dufour; Bae-Hoon Kim; John D MacMicking; Vincent Giguère; Philippe Gros
Journal:  PLoS Genet       Date:  2011-06-23       Impact factor: 5.917

10.  Severe malaria is associated with parasite binding to endothelial protein C receptor.

Authors:  Louise Turner; Thomas Lavstsen; Sanne S Berger; Christian W Wang; Jens E V Petersen; Marion Avril; Andrew J Brazier; Jim Freeth; Jakob S Jespersen; Morten A Nielsen; Pamela Magistrado; John Lusingu; Joseph D Smith; Matthew K Higgins; Thor G Theander
Journal:  Nature       Date:  2013-06-05       Impact factor: 49.962

View more
  32 in total

1.  Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease.

Authors:  Erica M Sparkenbaugh; Pichika Chantrathammachart; Kasemsiri Chandarajoti; Nigel Mackman; Nigel S Key; Rafal Pawlinski
Journal:  Blood       Date:  2016-01-27       Impact factor: 22.113

2.  Proteases, Protease-Activated Receptors, and Atherosclerosis.

Authors:  Wolfram Ruf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-06       Impact factor: 8.311

3.  Liang HPH, Kerschen EJ, Basu S, et al. Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice. Blood. 2015;126(21):2415-2423.

Authors: 
Journal:  Blood       Date:  2018-05-31       Impact factor: 22.113

Review 4.  Regulation of long-term repopulating hematopoietic stem cells by EPCR/PAR1 signaling.

Authors:  Shiri Gur-Cohen; Orit Kollet; Claudine Graf; Charles T Esmon; Wolfram Ruf; Tsvee Lapidot
Journal:  Ann N Y Acad Sci       Date:  2016-03-01       Impact factor: 5.691

5.  Characterization of Protease-Activated Receptor (PAR) ligands: Parmodulins are reversible allosteric inhibitors of PAR1-driven calcium mobilization in endothelial cells.

Authors:  Disha M Gandhi; Mark W Majewski; Ricardo Rosas; Kaitlin Kentala; Trevor J Foster; Eric Greve; Chris Dockendorff
Journal:  Bioorg Med Chem       Date:  2018-04-06       Impact factor: 3.641

Review 6.  Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis.

Authors:  Giovanni Cimmino; Plinio Cirillo
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

Review 7.  Endothelial cell protein C receptor-dependent signaling.

Authors:  Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Curr Opin Hematol       Date:  2018-05       Impact factor: 3.284

8.  Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.

Authors:  Yuichi Kamikubo; G Loredana Mendolicchio; Antonella Zampolli; Patrizia Marchese; Andrea S Rothmeier; Jennifer Nagrampa Orje; Andrew J Gale; Sriram Krishnaswamy; András Gruber; Henrik Østergaard; Lars C Petersen; Wolfram Ruf; Zaverio M Ruggeri
Journal:  Blood       Date:  2017-07-20       Impact factor: 22.113

9.  Myeloid cell-synthesized coagulation factor X dampens antitumor immunity.

Authors:  Claudine Graf; Petra Wilgenbus; Sven Pagel; Jennifer Pott; Federico Marini; Sabine Reyda; Maki Kitano; Stephan Macher-Göppinger; Hartmut Weiler; Wolfram Ruf
Journal:  Sci Immunol       Date:  2019-09-20

Review 10.  Targeting clotting proteins in cancer therapy - progress and challenges.

Authors:  Wolfram Ruf; Andrea S Rothmeier; Claudine Graf
Journal:  Thromb Res       Date:  2016-04       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.